# Usefulness of Continuous Glucose Monitoring in MODY Diagnosis

> **NCT05918484** · — · COMPLETED · sponsor: **Castilla-La Mancha Health Service** · enrollment: 500 (actual)

## Conditions studied

- Type 1 Diabetes
- MODY

## Interventions

- **DEVICE:** Intermittenly scanned continuous glucose monitoring
- **OTHER:** MODY genetic diagnostic test

## Key facts

- **NCT ID:** NCT05918484
- **Lead sponsor:** Castilla-La Mancha Health Service
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-01
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-01-31
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2025-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05918484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05918484, "Usefulness of Continuous Glucose Monitoring in MODY Diagnosis". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT05918484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*